Cyteir is a clinical-stage oncology company that is focused on the development of CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters. Cyteir’s current priority in CYT-0851 development is in combination with capecitabine and gemcitabine in a Phase 1/2 clinical study, including patients with advanced ovarian cancer.
View Top Employees from Cyteir Therapeutics| Website | http://www.cyteir.com |
| Ticker | CYT |
| Revenue | $5 million |
| Funding | $162.9 million |
| Employees | 39 (39 on RocketReach) |
| Founded | 2012 |
| Address | 128 Spring St Building A, Suite 510, Lexington, Massachusetts 02421, US |
| Phone | (857) 285-4140 |
| Technologies |
JavaScript,
HTML,
PHP
+26 more
(view full list)
|
| Industry | Research Services, Drug Manufacturing & Research, Biopharma, Pharmaceuticals, Biotechnology, Healthcare, Health Care, Science and Engineering, Pharmaceutical |
| Web Rank | 12 Million |
| Keywords | Cyteir Therapeutics, Autoimmunity |
| Competitors | ALX Oncology, Karus Therapeutics Limited, MIS.CARBONART, ORIC Pharmaceuticals Inc., arGEN-X N.V. |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Cyteir Therapeutics employee's phone or email?
Cyteir Therapeutics Questions
The Cyteir Therapeutics annual revenue was $5 million in 2024.
Susan Doleman is the Vice President Clinical Operations of Cyteir Therapeutics.
39 people are employed at Cyteir Therapeutics.
Cyteir Therapeutics is based in Lexington, Massachusetts.
The NAICS codes for Cyteir Therapeutics are [32, 541, 54, 325, 32541, 3254].
The SIC codes for Cyteir Therapeutics are [873, 87].
Top Cyteir Therapeutics Employees
-
15+
-
22
-
ViewSusan Doleman
Vice President Clinical Operations at Cyteir Therapeutics
Stoneham, Massachusetts, United States45+ -
24
-
33
-
View
Bill Bradley
Senior Director, Head of Translational Research at Cyteir Therapeutics
Lexington, MA, US33 -
ViewKrisztina Nemenyi
SVP Regulatory Affairs and Quality at Cyteir Therapeutics
Boston, Massachusetts, United States13 -
42
-
31
Related Companies
